Investor's Business Daily - Investing RSS http://ift.tt/1mfY3a9 Shares of Grifols (GRFS) have struggled after a report last week said the Spain-based pharmaceuticals company is investigating possible violations of the Foreign Corrupt Practices Act. The stock is trying to recover after plunging more than 6% below a 43.60 buy point Monday. It nearly triggered a sell rule before recovering to end in the top half of its intraday range. Monday's drop came after Compliance Week, a Boston-based corporate governance
No comments:
Post a Comment